A double-blind, placebo-controlled, randomized, multi-centre, phase III study of MLC901 (NeuroAiDTMII) for the treatment of cognitive impairment after mild traumatic brain injury

Pavel I. Pilipenko, Anna A. Ivanova, Yulia V. Kotsiubinskaya, Vera N. Grigoryeva, Alexey Y. Khrulev, Anatoly V. Skorokhodov, Maxim M. Gavrik, Nona N. Mkrtchan, Marek Majdan, Peter Valkovic, Daria Rabarova, Suzanne Barker-Collo, Kelly Jones, Valery L. Feigin

Open source

DOI: 10.1371/journal.pone.0310229
Published: 2025-07-10
Container: PLOS One
Publisher: Public Library of Science (PLoS)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1371/journal.pone.0310229,
  title = {A double-blind, placebo-controlled, randomized, multi-centre, phase III study of MLC901 (NeuroAiDTMII) for the treatment of cognitive impairment after mild traumatic brain injury},
  author = {Pavel I. Pilipenko and Anna A. Ivanova and Yulia V. Kotsiubinskaya and Vera N. Grigoryeva and Alexey Y. Khrulev and Anatoly V. Skorokhodov and Maxim M. Gavrik and Nona N. Mkrtchan and Marek Majdan and Peter Valkovic and Daria Rabarova and Suzanne Barker-Collo and Kelly Jones and Valery L. Feigin},
  year = {2025},
  journal = {PLOS One},
  doi = {10.1371/journal.pone.0310229},
  url = {https://doi.org/10.1371/journal.pone.0310229}
}

RIS

TY  - JOUR
TI  - A double-blind, placebo-controlled, randomized, multi-centre, phase III study of MLC901 (NeuroAiDTMII) for the treatment of cognitive impairment after mild traumatic brain injury
AU  - Pavel I. Pilipenko
AU  - Anna A. Ivanova
AU  - Yulia V. Kotsiubinskaya
AU  - Vera N. Grigoryeva
AU  - Alexey Y. Khrulev
AU  - Anatoly V. Skorokhodov
AU  - Maxim M. Gavrik
AU  - Nona N. Mkrtchan
AU  - Marek Majdan
AU  - Peter Valkovic
AU  - Daria Rabarova
AU  - Suzanne Barker-Collo
AU  - Kelly Jones
AU  - Valery L. Feigin
PY  - 2025
JO  - PLOS One
DO  - 10.1371/journal.pone.0310229
UR  - https://doi.org/10.1371/journal.pone.0310229
ER  -

APA

Pilipenko, P. I., Ivanova, A. A., Kotsiubinskaya, Y. V., Grigoryeva, V. N., Khrulev, A. Y., Skorokhodov, A. V., Gavrik, M. M., Mkrtchan, N. N., Majdan, M., Valkovic, P., Rabarova, D., Barker-Collo, S., Jones, K., & Feigin, V. L. (2025). A double-blind, placebo-controlled, randomized, multi-centre, phase III study of MLC901 (NeuroAiDTMII) for the treatment of cognitive impairment after mild traumatic brain injury. PLOS One. https://doi.org/10.1371/journal.pone.0310229

Source records

crossref · retrieved 2026-09-27T08:08:43.349Z